Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | INSM |
---|---|---|
09:32 ET | 6730 | 73.75 |
09:33 ET | 5172 | 74.055 |
09:35 ET | 2255 | 74.29 |
09:37 ET | 1050 | 74.577 |
09:39 ET | 989 | 74.575 |
09:42 ET | 1010 | 74.57 |
09:44 ET | 1444 | 74.18 |
09:46 ET | 1100 | 74.32 |
09:48 ET | 1606 | 74.53 |
09:50 ET | 1100 | 74.29 |
09:51 ET | 4632 | 74.15 |
09:53 ET | 1480 | 74.155 |
09:55 ET | 1141 | 74.215 |
09:57 ET | 400 | 74.01 |
10:00 ET | 1481 | 73.925 |
10:02 ET | 1163 | 73.86 |
10:04 ET | 900 | 73.86 |
10:06 ET | 300 | 73.95 |
10:08 ET | 2418 | 74.1 |
10:09 ET | 1390 | 74.085 |
10:11 ET | 2007 | 73.7 |
10:13 ET | 5542 | 73.74 |
10:15 ET | 1132 | 73.935 |
10:18 ET | 1200 | 73.82 |
10:20 ET | 2042 | 73.88 |
10:22 ET | 500 | 73.815 |
10:24 ET | 1850 | 73.73 |
10:26 ET | 3700 | 73.59 |
10:27 ET | 400 | 73.58 |
10:29 ET | 2596 | 73.8 |
10:31 ET | 400 | 73.82 |
10:33 ET | 595 | 73.82 |
10:36 ET | 1000 | 73.795 |
10:38 ET | 1690 | 73.94 |
10:40 ET | 1000 | 74.01 |
10:42 ET | 100 | 74.05 |
10:44 ET | 500 | 74.015 |
10:45 ET | 900 | 73.895 |
10:47 ET | 1213 | 73.99 |
10:49 ET | 100 | 73.975 |
10:51 ET | 700 | 73.99 |
10:54 ET | 891 | 74.05 |
10:56 ET | 100 | 74.075 |
10:58 ET | 300 | 74.115 |
11:00 ET | 1844 | 74.19 |
11:02 ET | 3383 | 74.28 |
11:03 ET | 1247 | 74.47 |
11:05 ET | 600 | 74.395 |
11:07 ET | 500 | 74.34 |
11:09 ET | 1268 | 74.275 |
11:12 ET | 2907 | 74.44 |
11:14 ET | 1000 | 74.25 |
11:16 ET | 200 | 74.25 |
11:18 ET | 3181 | 74.305 |
11:20 ET | 500 | 74.295 |
11:21 ET | 600 | 74.23 |
11:23 ET | 2340 | 74.38 |
11:25 ET | 400 | 74.385 |
11:27 ET | 200 | 74.51 |
11:30 ET | 500 | 74.495 |
11:32 ET | 400 | 74.505 |
11:34 ET | 2692 | 74.53 |
11:36 ET | 3264 | 74.67 |
11:38 ET | 200 | 74.68 |
11:39 ET | 2140 | 74.84 |
11:41 ET | 1291 | 74.81 |
11:43 ET | 1030 | 74.73 |
11:45 ET | 600 | 74.68 |
11:48 ET | 2870 | 74.66 |
11:50 ET | 200 | 74.69 |
11:52 ET | 2526 | 74.54 |
11:54 ET | 1500 | 74.5 |
11:56 ET | 2411 | 74.77 |
11:57 ET | 3945 | 75.095 |
11:59 ET | 1753 | 75.15 |
12:01 ET | 500 | 75.18 |
12:03 ET | 3356 | 75.05 |
12:06 ET | 500 | 75.13 |
12:08 ET | 733 | 75.15 |
12:10 ET | 2816 | 75.125 |
12:12 ET | 200 | 75.18 |
12:14 ET | 6325 | 74.93 |
12:15 ET | 12501 | 74.82 |
12:17 ET | 1450 | 74.81 |
12:19 ET | 403 | 74.815 |
12:21 ET | 7528 | 74.82 |
12:24 ET | 700 | 74.88 |
12:26 ET | 4160 | 74.55 |
12:28 ET | 763 | 74.62 |
12:30 ET | 500 | 74.605 |
12:32 ET | 3148 | 74.7 |
12:33 ET | 719 | 74.705 |
12:35 ET | 200 | 74.715 |
12:37 ET | 1237 | 74.705 |
12:39 ET | 1427 | 74.65 |
12:42 ET | 600 | 74.66 |
12:44 ET | 2870 | 74.88 |
12:46 ET | 3250 | 75 |
12:48 ET | 2401 | 74.89 |
12:50 ET | 200 | 74.93 |
12:51 ET | 1100 | 74.9 |
12:53 ET | 408 | 74.945 |
12:55 ET | 9130 | 75.245 |
12:57 ET | 2400 | 75.23 |
01:00 ET | 200 | 75.22 |
01:02 ET | 1200 | 75.21 |
01:04 ET | 600 | 75.13 |
01:06 ET | 2150 | 75.16 |
01:08 ET | 1137 | 74.96 |
01:09 ET | 1315 | 75.04 |
01:11 ET | 100 | 74.985 |
01:13 ET | 2608 | 75.15 |
01:15 ET | 3004 | 75.1 |
01:18 ET | 700 | 74.99 |
01:20 ET | 600 | 74.95 |
01:22 ET | 20938 | 75.21 |
01:24 ET | 31978 | 74.975 |
01:26 ET | 8419 | 75.09 |
01:27 ET | 2400 | 75.105 |
01:29 ET | 8250 | 74.93 |
01:31 ET | 3392 | 75.03 |
01:33 ET | 400 | 75.05 |
01:36 ET | 2900 | 74.875 |
01:38 ET | 2455 | 74.9 |
01:40 ET | 800 | 74.96 |
01:42 ET | 400 | 75 |
01:44 ET | 300 | 75.01 |
01:45 ET | 3160 | 75.175 |
01:47 ET | 1300 | 75.24 |
01:49 ET | 1100 | 75.19 |
01:51 ET | 200 | 75.255 |
01:54 ET | 900 | 75.19 |
01:58 ET | 1673 | 75.14 |
02:00 ET | 1249 | 75.17 |
02:02 ET | 200 | 75.17 |
02:03 ET | 400 | 75.19 |
02:05 ET | 1822 | 75.15 |
02:07 ET | 400 | 75.2 |
02:09 ET | 1103 | 75.26 |
02:12 ET | 6997 | 75.42 |
02:14 ET | 2805 | 75.36 |
02:16 ET | 1000 | 75.42 |
02:18 ET | 10173 | 75.525 |
02:20 ET | 2902 | 75.35 |
02:21 ET | 723 | 75.335 |
02:23 ET | 335 | 75.34 |
02:25 ET | 435 | 75.28 |
02:27 ET | 200 | 75.29 |
02:30 ET | 4437 | 75.23 |
02:32 ET | 100 | 75.19 |
02:34 ET | 200 | 75.22 |
02:36 ET | 900 | 75.28 |
02:38 ET | 6544 | 75.09 |
02:39 ET | 1042 | 75.24 |
02:41 ET | 100 | 75.22 |
02:43 ET | 1300 | 75.23 |
02:45 ET | 1200 | 75.23 |
02:48 ET | 11082 | 75.37 |
02:50 ET | 1848 | 75.37 |
02:52 ET | 1100 | 75.315 |
02:54 ET | 621 | 75.305 |
02:56 ET | 900 | 75.39 |
02:57 ET | 1209 | 75.36 |
02:59 ET | 2301 | 75.46 |
03:01 ET | 1200 | 75.475 |
03:03 ET | 4100 | 75.58 |
03:06 ET | 2600 | 75.6 |
03:08 ET | 2901 | 75.48 |
03:10 ET | 3045 | 75.59 |
03:12 ET | 1301 | 75.67 |
03:14 ET | 975 | 75.76 |
03:15 ET | 3659 | 75.72 |
03:17 ET | 3995 | 75.8 |
03:19 ET | 1998 | 75.99 |
03:21 ET | 7182 | 75.78 |
03:24 ET | 1200 | 75.765 |
03:26 ET | 1592 | 75.79 |
03:28 ET | 996 | 75.76 |
03:30 ET | 885 | 75.8 |
03:32 ET | 600 | 75.82 |
03:33 ET | 2999 | 75.81 |
03:35 ET | 1924 | 75.77 |
03:37 ET | 5055 | 75.735 |
03:39 ET | 4082 | 75.72 |
03:42 ET | 2700 | 75.66 |
03:44 ET | 8909 | 75.78 |
03:46 ET | 4423 | 75.8 |
03:48 ET | 19784 | 75.67 |
03:50 ET | 4893 | 75.65 |
03:51 ET | 6905 | 75.51 |
03:53 ET | 8633 | 75.72 |
03:55 ET | 10931 | 75.57 |
03:57 ET | 30305 | 75.73 |
04:00 ET | 241852 | 75.68 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Insmed Inc | 13.1B | -13.6x | --- |
Summit Therapeutics Inc | 14.0B | -69.4x | --- |
Vaxcyte Inc | 11.0B | -20.1x | --- |
Intra-Cellular Therapies Inc | 9.1B | -100.6x | --- |
Ascendis Pharma A/S | 7.9B | -17.2x | --- |
Tempus AI Inc | 9.2B | -7.1x | --- |
Insmed Incorporated is a global biopharmaceutical company. The Company's first commercial product, ARIKAYCE (amikacin liposome inhalation suspension), is used for the treatment of Mycobacterium avium complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. Its pipeline includes clinical-stage programs, brensocatib and TPIP, as well as other early-stage research programs. Brensocatib is a small molecule, oral, reversible inhibitor of dipeptidyl peptidase 1 (DPP1), which is developing for the treatment of patients with bronchiectasis and other neutrophil-mediated diseases, including chronic rhinosinusitis without nasal polyps (CRSsNP). TPIP is an inhaled formulation of the treprostinil prodrug treprostinil palmitil, which offers a differentiated product profile for pulmonary hypertension associated with interstitial lung disease (PH-ILD) and pulmonary arterial hypertension (PAH).
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $13.1B |
---|---|
Revenue (TTM) | $343.0M |
Shares Outstanding | 178.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.10 |
EPS | $-5.56 |
Book Value | $-2.24 |
P/E Ratio | -13.6x |
Price/Sales (TTM) | 38.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -240.88% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.